3 July 2024 true No description of principal activity Taxfiler 2024.6 15818025 business:PrivateLimitedCompanyLtd 2024-07-03 2025-07-31 15818025 2024-07-02 15818025 business:EntityHasNeverTraded 2024-07-03 2025-07-31 15818025 2024-07-03 2025-07-31 15818025 business:AuditExempt-NoAccountantsReport 2024-07-03 2025-07-31 15818025 business:FilletedAccounts 2024-07-03 2025-07-31 15818025 2025-07-31 15818025 business:Director1 2024-07-03 2025-07-31 15818025 business:RegisteredOffice 2024-07-03 2025-07-31 15818025 core:ShareCapital core:PreviouslyStatedAmount 2025-07-31 15818025 core:PreviouslyStatedAmount 2025-07-31 15818025 business:SmallEntities 2024-07-03 2025-07-31 15818025 countries:EnglandWales 2024-07-03 2025-07-31 iso4217:GBP xbrli:pure
Mycodisiacs Limited Company Information for the period from 3 July 2024 to 31 July 2025
Director
Kian De La Cour
Company Number
15818025 (England and Wales)
Registered Office
116 The Street Rockland St. Mary Norwich Norfolk NR14 7HQ England
Accountants
Bloodwood Accounting Ltd 50 Linden Road Birmingham B30 1JU
- 1 -
Mycodisiacs Limited Statement of financial position as at 31 July 2025
2025
Notes
£
Current assets
Cash at bank and in hand
100
Net current assets
100
Net assets
100
Capital and reserves
Called up share capital
100
Shareholders' funds
100
For the period ending 31 July 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 13 May 2026 and were signed on its behalf by
Kian De La Cour Director Company Registration No. 15818025
- 2 -
Mycodisiacs Limited Notes to the Accounts for the period from 3 July 2024 to 31 July 2025
1
Statutory information
Mycodisiacs Limited is a private company, limited by shares, registered in England and Wales, registration number 15818025. The registered office is 116 The Street, Rockland St. Mary, Norwich, Norfolk, NR14 7HQ, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Average number of employees
During the period the average number of employees was 0.
- 3 -